stella
beta
Safety and Efficacy of Recombinant Human Thyroid Stimulating Hormone for Adjuvant Diagnosis in Patients With Locally Advanced/Metastatic Differentiated Thyroid Cancer — Stella
Recruiting
Back to Recombinant Human Thyroid Stimulating Hormone trials
Not a traditional drug trial — this study doesn't follow the standard phase structure.
Trial locations
(1 site)
China
The First Affiliated Hospital of Nanjing Medical Univerity, Nanjing, Jiangsu
View full record on ClinicalTrials.gov